Arcutis Biotherapeutics (ARQT) Income Statement: Revenue & Earnings

Arcutis Biotherapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Arcutis Biotherapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	196.54	59.61	3.69	0.00	0.00
Cost of Revenue	19.13	4.99	0.75	0.00	0.00
Gross Profit	177.41	54.62	2.93	0.00	0.00
Operating Expenses
Research & Development	76.42	110.58	182.44	145.56	115.31
Selling, General & Administrative	229.39	185.15	122.12	60.97	21.34
Operating Expenses	305.81	295.72	304.56	206.53	136.65
Operating Income	-128.40	-241.10	-301.63	-206.53	-136.65
Other Income/Expense
Interest Income	16.17	11.79	5.82	0.17	0.97
Interest Expense	-27.17	-29.71	15.65	0.00	0.00
Other Income/Expense	16.17	11.79	5.82	-0.17	-0.97
Income
Income Before Tax	-139.39	-259.03	-311.46	-206.36	-135.68
Income Tax Expense	0.65	3.11	-12.26	-13.39	-9.21
Net Income	-140.04	-262.14	-311.46	-206.36	-135.68
Net Income - Continuous Operations	-140.04	-262.14	-311.46	-206.36	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-125.80	-239.58	-294.87	-205.90	-135.56
EBIT	-128.40	-241.10	-295.81	-206.36	-135.68
Depreciation & Amortization	2.60	1.52	0.62	0.45	0.12
Earnings Per Share
Basic EPS	-1.00	-4.00	-6.00	-4.00	-4.00
Diluted EPS	-1.00	-4.00	-6.00	-4.00	-4.00
Basic Shares Outstanding	120.96	69.31	55.03	49.41	35.67
Diluted Shares Outstanding	120.96	69.31	55.03	49.41	35.67